Sign Up Today and Learn More About Neuromod Devices Stock
Invest in or calculate the value of your shares in Neuromod Devices or other pre-IPO companies through EquityZen's platform.
Neuromod Devices Stock (NEDE)
Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
About Neuromod Devices Stock
Founded
2010
Industries
Software, Artificial Intelligence, Data and Analytics
Neuromod Devices Press Mentions
Stay in the know about the latest news on Neuromod Devices
Irish MedTech Company Neuromod Expands Lenire Availability to Canada and Australia Creating 25 Jobs
prnewswire • Feb 26, 2026
Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study
prnewswire • Feb 17, 2026
Tinnitus UK Rates Lenire as Most Effective Treatment Option
prnewswire • Nov 05, 2025
Tinnitus UK Rates Lenire as Most Effective Treatment Option
prnewswire • Nov 05, 2025
Neuromod Launches Online Tinnitus Masterclass
prnewswire • Oct 21, 2025
Neuromod Devices Management
Leadership team at Neuromod Devices
CHIEF FINANCIAL OFFICER
Derek Madden
Chief Commercial Officer
Florian Elsaesser
Join now and verify your accreditation status to gain access to:
- Neuromod Devices Current Valuation
- Neuromod Devices Stock Price
- Neuromod Devices Management
- Available deals in Neuromod Devices and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Neuromod Devices Cap Table and Funding History by Share Class and Liquidity Preferences
- Neuromod Devices Revenue and Financials
- Neuromod Devices Highlights
- Neuromod Devices Business Model
- Neuromod Devices Risk Factors
- Neuromod Devices Research Report from SACRA Research
Trading Neuromod Devices Stock
How to invest in Neuromod Devices stock?
Accredited investors can buy pre-IPO stock in companies like Neuromod Devices through EquityZen funds. These investments are made available by existing Neuromod Devices shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Neuromod Devices stock?
Shareholders can sell their Neuromod Devices stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
